https://doi.org/10.1056/nejmoa0802885
W
Weihong Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
86
Papers
20.0K
Citations
35
h-index
50
i10-index
Weihong Xu is an academic researcher from National Cancer Institute. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Immune Cell Function and Interaction. The author has an h-index of 35, co-authored 74 publications.
ORCID: 0000-0002-3988-3571Papers by this author
worksStromal Gene Signatures in Large-B-Cell Lymphomas
2008 · New England Journal of Medicine · 1,797 citations
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
2012 · Nature · 909 citations
https://doi.org/10.1038/nature11378
Genome-wide inactivation of porcine endogenous retroviruses (PERVs)
2015 · Science · 605 citations
https://doi.org/10.1126/science.aad1191
Extensive germline genome engineering in pigs
2020 · Nature Biomedical Engineering · 162 citations
https://doi.org/10.1038/s41551-020-00613-9
Genome-wide mapping of ORC and Mcm2p binding sites on tiling arrays and identification of essential ARS consensus sequences in S. cerevisiae
2006 · BMC Genomics · 120 citations
https://doi.org/10.1186/1471-2164-7-276
A method for high‐throughput production of sequence‐verified <scp>DNA</scp> libraries and strain collections
2017 · Molecular Systems Biology · 59 citations
https://doi.org/10.15252/msb.20167233
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat